Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

  1. Cequier, Á.
  2. Arrarte, V.
  3. Campuzano, R.
  4. Castro, A.
  5. Cordero, A.
  6. Fernández Olmo, M.R.
  7. García-Moll, X.
  8. Gómez Doblas, J.J.
  9. López de Sá, E.
  10. Núñez, J.
  11. Pintó Sala, X.
  12. Cosín, J.
  13. González Juanatey, J.R.
  14. Zamorano, J.L.
  15. Anguita, M.
  16. Rodríguez Padial, L.
  17. López Sendón, J.L.
Journal:
REC: CardioClinics

ISSN: 2605-1575 2605-1532

Year of publication: 2021

Volume: 56

Issue: 1

Pages: 39-48

Type: Article

DOI: 10.1016/J.RCCL.2020.10.017 GOOGLE SCHOLAR

Sustainable development goals